• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Behavioural therapies

Bibliographic informationStudy type and evidence levelNumber of patientsPatient characteristicsIntervention and comparisonFollow-up and outcome measuresEffect sizeReviewer comments
Hampel P; Rudolph H; Petermann F; Stachow R; 2001496Study Type: Cohort

Evidence level: 2−
n= 60 in total

n= 44 at follow up assessment of which n=25 for the experimental group, n=19 for the control group
Children with a mean age of 12.64 years (n=44) diagnosed with atopic eczema (mean SCORAD 37.9 SD 15.54 (n=60))Intervention: Cognitive-behavioral based stress management training
10 one hour training sessions
4 sessions standard patient education regime according to German guidelines 6 sessions of 'anti- stress training'

Comparison: Standard patient education program 6 sessions
Follow-up period: 6 months

Outcome Measures: SCORAD index for severity of disease

German Coping questionnaire (Stressverarbeitungsfrag ebogen SVF-KJ)

performed at time 0,1month, 6 months
Immediately after treatment (1 month) both groups showed a significant reduction in disease severity (p<0.001) regarding the SCORAD index.

At 6 months, the cognitive- behavioural stress management training led to improvements in subjective health status (post hoc analysis) and the ability to cope with common stressors
Study is EL= 2− as it is a non-randomised controlled study, with large dropout at 6 months. Post hoc analysis. Language, quality of write up and statistical presentation difficult to interpret.

The funding of the study is unknown

From: Evidence tables

Cover of Atopic Eczema in Children
Atopic Eczema in Children: Management of Atopic Eczema in Children from Birth up to the Age of 12 Years.
NICE Clinical Guidelines, No. 57.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2007 Dec.
Copyright © 2007, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.